References
Groger M, Veletzky L, Lalremruata A, Cattaneo C, Mischlinger J, Zoleko-Manego R, et al (2018) Prospective clinical trial assessing species-specific efficacy of artemether-lumefantrine for the treatment of plasmodium malariae, plasmodium ovale, and mixed plasmodium malaria in gabon. Antimicrob Agents Chemother 62(3). https://doi.org/10.1128/aac.01758-17
Tournoy TK, Rosanas-Urgell A, Van Esbroeck M, Bottieau E, Huits R (2022) Plasmodium malariae after successful treatment of P falciparum malaria with artemether-lumefantrine. Int J Infect Dis 119:56–8
Author information
Authors and Affiliations
Contributions
MAQF collected clinical data. DN and FL collected the laboratory data. DN, FL and MAQF wrote the initial draft. CR, CVC and JMC critically reviewed and finished writing the paper. All authors contributed equally to research and analysis of the case.
Corresponding author
Ethics declarations
Competing Interests
The authors have no competing interests. No conflicts of interest declared.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nunes, D., Luís, F., Flores, M.A.Q. et al. Co-Infectious Mystery: Why Artemether-Lumefantrine Cleared P. falciparum but Left P. malariae behind. Indian J Hematol Blood Transfus (2024). https://doi.org/10.1007/s12288-024-01766-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12288-024-01766-2